Constellations, Launch, New Space and more…
Merck, Procter & Gamble Among Private-Sector Partners Launching Research to the ISS on SpaceX CRS-24

KENNEDY SPACE CENTER, Fla., December 13, 2021 (CASIS PR) – SpaceX’s upcoming 24th Commercial Resupply Services (CRS) mission to the International Space Station (ISS) will include more than 15 payloads sponsored by the ISS National Laboratory, managed by the Center for the Advancement of Science in Space, Inc. (CASIS). These payloads include multiple investigations from private-sector entities, including two supported by highly recognizable companies: Merck and Procter & Gamble.

  • Parabolic Arc
  • December 14, 2021
Space Life Sciences Lab Sends Experiments to ISS

EXPLORATION PARK, Fla. (Space Florida PR) — Space Florida is proud to congratulate SpaceX for the successful docking of the CRS-10 mission with the ISS and to congratulate the 4 different experiments on board the Dragon capsule which were processed in the Space Life Sciences Lab (SLSL) in Exploration Park, Florida. Those experiments were as follows: Customer: CASIS/MERCK PI: Paul Reichert Protein crystal growth – pharmaceutical research (chemotherapy) Customer: Edith […]

  • Parabolic Arc
  • February 27, 2017
CASIS Releases FY 2015 Annual Report

MELBOURNE, Fla. (CASIS PR) — We are pleased to share with you the FY2015 CASIS Annual Report. As the managers of the International Space Station (ISS) U.S. National Laboratory, The Center for Advancement of Science in Space (CASIS) works closely with NASA and ISS National Lab partners to maximize the impact of research and development on the ISS to directly benefit life on Earth. Inside this year’s report you will find many […]

  • Parabolic Arc
  • January 15, 2016
CASIS-Sponsored Research Arrives at ISS

casis_new_logoKENNEDY SPACE CENTER, FL. (April 17, 2015) – The fifth series of payloads sponsored by the Center for the Advancement of Science in Space (CASIS) successfully berthed to the International Space Station (ISS) onboard Space Exploration Technologies Corporation’s (SpaceX) Dragon capsule. CASIS is tasked with managing and promoting research onboard the ISS U.S. National Laboratory.

Research onboard the SpaceX Dragon capsule includes a range of experiments sponsored by CASIS from the commercial and academic communities. Below is an overview of the major payloads sponsored by CASIS:

Osteo-4 (NIH Transitioned Payload)
PI: Paola Divieti Pajevic, MD, Ph.D., Boston, MA, United States

Osteocytes and Mechanomechano-transduction (Osteo-4) studies the effects of microgravity on the function of osteocytes, which are the most common cells in bone. These cells reside within the mineralized bone and can sense mechanical forces, or the lack of them, but researchers do not know how. Osteo-4 allows scientists to analyze changes in the physical appearance and genetic expression of mouse bone cells in microgravity.

  • Parabolic Arc
  • April 21, 2015
CASIS, Merck in Deal to Conduct Therapeutic Research on ISS

KENNEDY SPACE CENTER, FL., September 10, 2012 (CASIS PR) – The Center for the Advancement of Science in Space (CASIS) – manager of the International Space Station (ISS) U.S. National Laboratory – today announced that it is collaborating with global healthcare company Merck to conduct cutting-edge therapeutic research on board the ISS in 2013.

The ISS-based research will focus on therapeutic monoclonal antibodies (MABs), which are engineered proteins designed to bind to targets that cause disease, potentially allowing greater specificity than conventional therapies with fewer side effects.


  • Parabolic Arc
  • September 10, 2012